Bestopick Life Sciences Private Limited
About Bestopick Life Sciences Private Limited
Data last updated:
Bestopick Life Sciences Private Limited is a private limited company based in Hapur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2010PTC039426. Its GSTIN is 09AADCB9917H1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.75 Lakh. It is led by directors Suman Lata and Niketa Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 76 Sanjay Vihar Meerut Road, Hapur, Uttar Pradesh, India – 245101.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.47 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹34,238 (net margin 1.2%) and EBITDA of ₹39,253 (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bestopick Life Sciences Private Limited's registered office is in Hapur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 76 Sanjay Vihar Meerut Road, Hapur, Uttar Pradesh, India – 245101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bestopick Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bestopick Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bestopick Life Sciences Private Limited, buy the company report.
Financials of Bestopick Life Sciences Private Limited
FY 2025 filings availableBestopick Life Sciences Private Limited reported revenue of ₹28.47 Lakh (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 29% over five years, including a 17% fall in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39,253 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,238 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bestopick Life Sciences Private Limited, buy the company report.
Board of directors of Bestopick Life Sciences Private Limited
Bestopick Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Lata Also directs: Omex Biotech Private Limited, Uniplus Biotech Private Limited | Director | 21 Aug 2019 | 7 Years 2 Months | Current |
| Niketa Tyagi Also directs: Omex Biotech Private Limited, Uniplus Biotech Private Limited | Director | 11 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Bestopick Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| R N Medicare Private Limited | ₹28.52 Lakh (FY 2024) | 0.0% | Mumbai, Maharashtra, India | |||
| Bestopick Life Sciences Private Limitedthis company | ₹28.47 Lakh (FY 2024) | ₹34,238 | 1.2% | -17.0% | Hapur, Uttar Pradesh, India | |
| Crystal Variety Remedies Private Limited | ₹28.25 Lakh (FY 2019) | -27.0% | Thrissur, Kerala, India | |||
| Kurao Chemicals Private Limited | ₹28.23 Lakh (FY 2025) | 19.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Bestopick Life Sciences Private Limited, buy the company report.
Auditor
Bestopick Life Sciences Private Limited is audited by UMESH MITTAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UMESH MITTAL & ASSOCIATES | FY 2021 | 005671C |
Shareholding
The shareholding of Bestopick Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Bestopick Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bestopick Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bestopick Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bestopick Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCB9917H1ZE | Uttar Pradesh | Active | 25 Aug 2017 |
To see the full GST registrations and return filing status of Bestopick Life Sciences Private Limited, buy the company report.
Recent activity
Bestopick Life Sciences Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Niketa Tyagi ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Bestopick Life Sciences is an active private limited company based in Hapur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 February 2010 (16+ years old) and is registered under CIN U24233UP2010PTC039426.
Bestopick Life Sciences has 2 current directors:
- Suman Lata - Director
- Niketa Tyagi - Director
The latest financial statements of Bestopick Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bestopick Life Sciences is 09AADCB9917H1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bestopick Life Sciences is U24233UP2010PTC039426. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bestopick Life Sciences was incorporated on 02 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Bestopick Life Sciences by revenue are R N Medicare Private Limited, Crystal Variety Remedies Private Limited, Kurao Chemicals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Niketa Tyagi ceased to be Additional Director on 30 Nov 2021. Niketa Tyagi was appointed as Director on 11 Jun 2021. Bratpal Singh Tyagi ceased to be Director on 21 May 2021. Bestopick Life Sciences has 6 board changes on record in total.
The registered office of Bestopick Life Sciences is at C – 76 Sanjay Vihar Meerut Road, Hapur, Uttar Pradesh, India – 245101.
Bestopick Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Bestopick Life Sciences is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.